Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.

Charity organisation Sickle Cell Society has described the recommendation as a “major breakthrough” for sickle cell patients.

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

People in England with sickle cell will be able to get the world’s first CRISPR-based medicine under an agreement between the ...

CRISPR Therapeutics' stock decline is likely influenced by Editas Medicine's struggles, but CRISPR remains a distinct and stronger company with a promising long-term outlook. CRISPR's strategic ...

Efficiency: Advances in sgRNA design and delivery systems ensure higher success rates in genome-wide studies. These benefits make CRISPR libraries an essential tool in both academic and industrial ...

Cynthia Sass is a nutritionist and registered dietitian with master's degrees in both nutrition science and public health. Frequently seen on national TV, she's Health's contributing nutrition ...

So while scientists keep venturing into tweaking our DNA, it is worth taking the time to fully understand what CRISPR is, and what the actual benefits and possibilities are. CRISPR is short for ...

CRISPR Therapeutics stock could more than double from recent prices, according to analysts from Bank of America and Truist. CRISPR Therapeutics earned approval for its first drug over a year ago ...